Patent · US Active

Listeria-based adjuvants

US10064898B2 · kind B2 · utility

7Cited by

89References

14Claims

0Family size

Assignees

Advaxis, Inc. · US
University of Georgia Research Foundation, Inc. · US
The Trustees of the University of Pennsylvania · US

Inventors

John Rothman · Lebanon, US
Anu Wallecha · Yardley, US
Reshma Singh · Cambridge, US
Donald A. Harn · Pembroke, US
Yvonne Paterson · Philadelphia, US

Key dates

Filing date	Jul 27, 2016
Grant date	Sep 4, 2018
Priority date	—
Expiry date	Jul 27, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides methods and compositions for using Listeria monocytogenes as an adjuvant for enhancing immune responses in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.